Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101928269 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM118B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R5C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WWOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSIG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SDAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNRPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01563 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPKAPK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERLIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THADA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on